| Dr Robert Glenn Thilo, MD | |
|
7215 Se 32nd St, Mercer Island, WA 98040-2640 | |
| (206) 462-5199 | |
| (866) 334-9417 |
| Full Name | Dr Robert Glenn Thilo |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 7215 Se 32nd St, Mercer Island, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285789743 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 025209 MD00021350 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Glenn Thilo, MD 7215 Se 32nd St, Mercer Island, WA 98040-2640 Ph: (206) 462-5199 | Dr Robert Glenn Thilo, MD 7215 Se 32nd St, Mercer Island, WA 98040-2640 Ph: (206) 462-5199 |
News Archive
This week's issue of the Lancet "has an HIV theme ahead of the International AIDS Society meeting in Washington, D.C., ... on July 22-27," a Lancet editorial states, noting, "The issue of antiretrovirals for prevention, specifically pre-exposure prophylaxis, is presently under intense debate."
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
VaxGen, Inc. announced today the completion of its merger transaction with diaDexus, Inc., a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease.
A single dose of an FDA-approved intravenous nutrition source may be able to significantly reduce the toxicity and increase the bioavailability of platinum-based cancer drugs, according to a study by Carnegie Mellon University biologists published in Scientific Reports.
Constellation Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing new drugs targeting epigenetic regulation of the human genome, today announced that it has raised $22 million in a Series B financing round.
› Verified 4 days ago
Dr. Ryan Matthew Fugate, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7525 Se 24th St Ste 400, Mercer Island, WA 98040 Phone: 206-230-0330 Fax: 206-230-0336 | |
Dr. David Louis Dunner, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7525 Se 24th St, Suite 400, Mercer Island, WA 98040 Phone: 206-230-0330 Fax: 206-230-0336 | |
Dr. Richard Eduardo Repass, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2737 78th Ave Se, Mercer Island, WA 98040 Phone: 425-652-4812 Fax: 425-818-3821 | |
Dr. Kevin Lawrence Sloan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8015 Se 28th St, Suite 218, Mercer Island, WA 98040 Phone: 206-375-2774 | |
Dr. Mary G Bartels, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7254 91st Ave Se, Mercer Island, WA 98040 Phone: 206-679-9084 | |
Dr. Thucuc Thi-thu Nguyen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9725 Se 36th St, Suite, Mercer Island, WA 98040 Phone: 206-236-5553 Fax: 206-236-0506 |